Stock MXCT MAXCYTE, INC.
Add to a list
To use this feature you must be a member
Log inSign up

MarketScreener Editorial Features MaxCyte, Inc.

Equities

MXCT

US57777K1060

Delayed London S.E.
Other stock markets
 06:15:23 2024-05-02 am EDT 		5-day change 1st Jan Change
291.1 GBX -1.32% Intraday chart for MaxCyte, Inc. -9.88% -17.42%
Apr. 02 MaxCyte, Inc. Signs Strategic Platform License with Be Biopharma to Support the Development of Engineered B Cell Medicines CI
Mar. 13 BTIG Adjusts Price Target on MaxCyte to $8 From $10, Maintains Buy Rating MT

MarketScreener Editorial Features

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
FTSE 100 rises ahead of US inflation dataFTSE 100 rises ahead of US inflation data December 12, 2023 at 04:47 am EST
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. MXCT Stock
  4. News MaxCyte, Inc.
  5. MarketScreener Editorial Features